Zynex Liabilities And Stockholders Equity from 2010 to 2024

ZYXI Stock  USD 8.34  0.08  0.97%   
Zynex's Liabilities And Stockholders Equity is increasing with slightly volatile movements from year to year. Liabilities And Stockholders Equity is estimated to finish at about 143.7 M this year. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Zynex's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
1999-06-30
Previous Quarter
121.9 M
Current Value
126.1 M
Quarterly Volatility
42.6 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zynex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zynex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.4 M, Interest Expense of 1.1 M or Total Revenue of 193.5 M, as well as many indicators such as Price To Sales Ratio of 2.0, Dividend Yield of 0.0 or PTB Ratio of 7.97. Zynex financial statements analysis is a perfect complement when working with Zynex Valuation or Volatility modules.
  
Check out the analysis of Zynex Correlation against competitors.

Latest Zynex's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Zynex Inc over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Zynex's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zynex's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Zynex Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean49,051,621
Geometric Mean11,767,705
Coefficient Of Variation112.35
Mean Deviation47,641,346
Median21,785,000
Standard Deviation55,107,558
Sample Variance3036.8T
Range143.7M
R-Value0.83
Mean Square Error1006.9T
R-Squared0.69
Significance0.0001
Slope10,251,402
Total Sum of Squares42515.8T

Zynex Liabilities And Stockholders Equity History

2024143.7 M
2023136.9 M
2022116.5 M
2021133.3 M
202072.2 M
201928.3 M
201816.2 M

About Zynex Financial Statements

Investors use fundamental indicators, such as Zynex's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Zynex's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity136.9 M143.7 M

Currently Active Assets on Macroaxis

When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:
Check out the analysis of Zynex Correlation against competitors.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
0.14
Revenue Per Share
5.984
Quarterly Revenue Growth
0.001
Return On Assets
0.0399
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.